KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) EBT (2016 - 2025)

Illumina (ILMN) has disclosed EBT for 17 consecutive years, with $378.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 102.14% year-over-year to $378.0 million, compared with a TTM value of $1.1 billion through Dec 2025, up 192.19%, and an annual FY2025 reading of $1.1 billion, up 192.11% over the prior year.
  • EBT was $378.0 million for Q4 2025 at Illumina, up from $220.0 million in the prior quarter.
  • Across five years, EBT topped out at $720.0 million in Q3 2024 and bottomed at -$5.1 billion in Q1 2023.
  • Average EBT over 5 years is -$470.7 million, with a median of $154.5 million recorded in 2021.
  • The sharpest move saw EBT crashed 2120.22% in 2024, then surged 266.97% in 2025.
  • Year by year, EBT stood at $420.0 million in 2021, then tumbled by 974.29% to -$3.7 billion in 2022, then soared by 95.45% to -$167.0 million in 2023, then skyrocketed by 211.98% to $187.0 million in 2024, then skyrocketed by 102.14% to $378.0 million in 2025.
  • Business Quant data shows EBT for ILMN at $378.0 million in Q4 2025, $220.0 million in Q3 2025, and $306.0 million in Q2 2025.